The connected healthcare IT provider has closed a Qualcomm-led series B round that increased its overall funding to $17m.
Month: October 2015
Access gets a sense of Humacyte in $150m round
Phaarmaceutical company Humacyte has raised $150m in an Access Industries-backed series B round that will fund phase 3 trials for its renal disease technology.
Wang takes principal role at HCRP
Conrad Wang has left Medtronic, where he oversaw corporate venturing investments and acquisitions, to join investment firm Healthcare Royalty Partners.
World of corporate venturing 2016 survey
Answer our annual survey which tracks what is going on in corporate venturing.
Merck-backed BeiGene targets $100m in US flotation
China-based immuno-oncology company BeiGene, which has raised more than $170m in the past year, will advance four of its drug candidates with the proceeds.
Vipshop likes what it sees in Showroomprive IPO
Vipshop will pay $34m for a stake in flash sales site Showroomprive, which is seeking $339m in a Paris IPO.
Leshi revs up $700m Yidao Yongche investment
The online media company will acquire a 70% stake in car sharing service Yongche, which is backed by Qualcomm, Ctrip and Baidu.
Alibaba and Foxconn announce incubator programme
Taofu Chengzhen, which has been trialled for the past six months, is a joint venture between Foxconn and Alibaba’s cloud computing subsidiary.
3M helps deliver series B funding for Impel
3M has led the first tranche of the drug delivery technology company’s $12m series B round, closed in conjunction with the formation of an alliance with 3M Drug Delivery Systems.
HTC pays for admission to Surgical Theater
The surgical imaging technology developer closed a $9m round today that was co-led by HTC, the producer of a virtual reality headset compatible with the technology.
FollowAnalytics engages Salesforce for $10m series A
The mobile engagement platform developer has now raised $13.5m in the past two years, and will use the cash to beef up its sales and marketing.
FosunPharma makes Astute investment
Fosun’s pharmaceutical wing invested $20m in the diagnostic testing technology company as part of a strategic partnership, boosting its overall equity funding to $115m.
Jiuxian to serve up IPO
The Yuekeung Winery-backed alcohol e-commerce company, which has raised about $225m in funding, has had a Chinese IPO approved.
Lyra recommends itself for $35m
The mental health treatment recommendation provider secured the money in a round backed by Providence Health & Services and strategic partner Castlight Health.